FAP and cancer: Several recently developed quinolone-based FAP inhibitors (FAPIs) coupled to chelators, including gallium-68 (68Ga)-labelled FAPI, are advantageous in staging and restaging many cancers, including peritonitis carcinomatosis, compared with [18F]F-FDG PET/CT (9–11).